The Joint Corp

Company Profile

The Joint Corp had its IPO on 2014-11-11 under the ticker symbol JYNT.

The company operates in the Healthcare sector and Medical Care Facilities industry. The Joint Corp has a staff strength of 359 employees.

Stock update

Shares of The Joint Corp opened at $9.54 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $9.45 - $9.59, and closed at $9.52.

This is a -0.52% slip from the previous day's closing price.

A total volume of 83,738 shares were traded at the close of the day’s session.

In the last one week, shares of The Joint Corp have increased by +1.06%.

The Joint Corp's Key Ratios

The Joint Corp has a market cap of $140.48 million, indicating a price to book ratio of 7.4815 and a price to sales ratio of 2.2429.

In the last 12-months The Joint Corp’s revenue was $107.92 million with a gross profit of $92.08 million and an EBITDA of $10.40 million. The EBITDA ratio measures The Joint Corp's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, The Joint Corp’s operating margin was 1.89% while its return on assets stood at 1.4% with a return of equity of 11.36%.

In Q1, The Joint Corp’s quarterly earnings growth was a negative -76.9% while revenue growth was a positive 26.8%.

The Joint Corp’s PE and PEG Ratio

Forward PE

55.8659

Trailing PE

38.28

PEG

-0.7

Its diluted EPS in the last 12-months stands at $0.25 per share while it has a forward price to earnings multiple of 55.8659 and a PEG multiple of -0.7. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into The Joint Corp’s profitability.

The Joint Corp stock is trading at a EV to sales ratio of 2.5976 and a EV to EBITDA ratio of 30.0004. Its price to sales ratio in the trailing 12-months stood at 2.2429.

The Joint Corp stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$98.05 million

Total Liabilities

$24.97 million

Operating Cash Flow

$-1200215.00

Capital Expenditure

$1.20 million

Dividend Payout Ratio

0%

The Joint Corp ended 2024 with $98.05 million in total assets and $0 in total liabilities. Its intangible assets were valued at $98.05 million while shareholder equity stood at $35.08 million.

The Joint Corp ended 2024 with $0 in deferred long-term liabilities, $24.97 million in other current liabilities, 14671.00 in common stock, $-10040856.00 in retained earnings and $8.49 million in goodwill. Its cash balance stood at $14.77 million and cash and short-term investments were $14.77 million. The company’s total short-term debt was $5,647,269 while long-term debt stood at $2.00 million.

The Joint Corp’s total current assets stands at $23.56 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $3.53 million compared to accounts payable of $1.84 million and inventory worth $1.79 million.

In 2024, The Joint Corp's operating cash flow was $-1200215.00 while its capital expenditure stood at $1.20 million.

Comparatively, The Joint Corp paid $0 in dividends in 2024.

Other key metrics

Current Trading Price

$9.52

52-Week High

$20

52-Week Low

$8.92

Analyst Target Price

$29.9

The Joint Corp stock is currently trading at $9.52 per share. It touched a 52-week high of $20 and a 52-week low of $20. Analysts tracking the stock have a 12-month average target price of $29.9.

Its 50-day moving average was $11.79 and 200-day moving average was $14.58 The short ratio stood at 5.31 indicating a short percent outstanding of 0%.

Around 137.1% of the company’s stock are held by insiders while 8422.8% are held by institutions.